Celanese to conduct research, prototype development and characterization of a refillable contraceptive technology with award from the Bill & Melinda Gates Foundation
Highlighted as game changer in drug development & delivery special feature on innovative technologies for improving drug solubility and bioavailability
State-of-the-art R&D lab expands technical feasibility capabilities for long-acting delivery of small molecules, biologics, nucleotides
Nanoform and Celanese intend to work on formulation development, leveraging each organization's unique formulation expertise.
The base Gland business posted ?11,790 million in revenue, up 16% YoY
Stevens succeeds Milton Boyer, who has stepped down as CEO but will remain closely involved with the business as an independent member of Kindeva’s Board of Directors
The BD Neopak Glass Prefillable Syringe platform is designed for the complex needs of biologics and combination products
Supports production of AbbVie's current and next-generation immunology and neuroscience medicines
The agreement, signed in December 2025, grants Takeda an exclusive worldwide license to use Halozyme’s proprietary recombinant human hyaluronidase PH20 enzyme (rHuPH20) with vedolizumab
Subscribe To Our Newsletter & Stay Updated
